Chagas cardiomyopathy associated with serological cure after trypanocidal treatment during childhood
Abstract Chagas disease is a chronic parasitological disease, which could cause cardiac manifestations in approximately one-third of affected individuals. Benznidazole and nifurtimox are used to treat this parasitological infection caused by Trypanosoma cruzi. Conventionally, the criterion for cure...
Main Authors: | Marisa Liliana Fernández, Yolanda Hernández, Karenina Scollo, Mónica Ines Esteva, Adelina Rosa Riarte, Nilda Graciela Prado |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical (SBMT)
|
Series: | Revista da Sociedade Brasileira de Medicina Tropical |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822018000400557&lng=en&tlng=en |
Similar Items
-
The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease
by: J Antonio Marin-Neto, et al.
Published: (2009-07-01) -
Chagas cardiomyopathy and serologic testing in a small rural hospital in Chiapas, Mexico Miocardiopatía chagásica y pruebas serológicas de enfermedad de Chagas en un hospital rural pequeño de Chiapas, México
by: Linnea Capps, et al.
Published: (2004-05-01) -
Comparação do desfecho entre a cardiopatia chagásica e a miocardiopatia dilatada idiopática Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy
by: Amanda Pires Barbosa, et al.
Published: (2011-12-01) -
Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
by: Paula Simplício da Silva, et al.
Published: (2017-06-01) -
Immunopathologic studies in myocardial biopsies of patients with Chagas' disease and idiopathic cardiomyopathy
by: Maria de Lourdes Higuchi, et al.
Published: (1986-04-01)